BackNLS Pharmaceutics Overview

NLS Pharmaceutics Other Income Expense Net

Other Income/Expense Net for NLSP.

Quarterly Other Income/Expense

-$441456.00
↓ 2600.18% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

$1.66M
↑ 244.19% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin